Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ELL3 |
| Upstream (Parents) |
|---|
| (<<) CALML4 → ELL3 |
| (<<) C5orf30 → ELL3 |
| (<<) CKMT1A///CKMT1B → ELL3 |
| (<<) LPCAT4 → ELL3 |
| (<<) BCL2L14 → ELL3 |
| (<<) HIST3H2A → ELL3 |
| (<<) MST4 → ELL3 |
| Downstream (Children) |
|---|
| ELL3 → GATA3 (>>) |
| ELL3 → IL4 (>>) |
| ELL3 → RHBDL1 (>>) |
| ELL3 → PRKDC (>>) |
| ELL3 → ATXN8OS (>>) |
| ELL3 → PAQR5 (>>) |
| ELL3 → RBP1 (>>) |
| ELL3 → AURKC (>>) |
| ELL3 → EIF5A (>>) |
| ELL3 → SLC6A9 (>>) |
| ELL3 → ZNF442 (>>) |
| ELL3 → ANXA2P3 (>>) |
